A joint DHL + Mærsk effort – what investors want
From a formidable duo to pale face
THE WALL STREET JOURNAL reports:
Johnson & Johnson is poised to begin a roadshow to pitch shares of its consumer-healthcare business, the producer of household names such as Tylenol, in a test for an IPO market that has been in the doldrums for the past year.
Kenvue Inc. plans to start meeting with prospective investors as early as Monday, people familiar with the matter said. The goal is to raise $3.5 billion or more in the offering at a valuation close to ...
Peak season hopes dashed as freight rates slip again
CMA CGM liner trades pummelled in Q1 – and there's worse to come
Airlines that adapt quickly will survive likely freight pain in H2
Pessimistic Yang Ming to refocus on 3PL, terminals and yards
Freight slump does not stop US inland ports’ advance
Mexican rail seizures give near-shoring interests pause for thought
Digital forwarder Freightwalla's failure reveals home truths
Comment on this article